Association between neonatal hyperglycemia and retinopathy of prematurity: a meta-analysis
- PMID: 34114080
- DOI: 10.1007/s00431-021-04140-w
Association between neonatal hyperglycemia and retinopathy of prematurity: a meta-analysis
Abstract
Through a meta-analysis, we aimed to investigate whether neonatal hyperglycemia was associated with an increased risk of retinopathy of prematurity (ROP) by summarizing all available observational evidence. We searched online databases for studies published prior to December 2020; 26745 neonates with 3227 cases of ROP in 11 case-control studies and 997 neonates with 496 cases of hyperglycemia in 5 cohort studies were included. The results showed that the association between hyperglycemia and the occurrence of ROP was statistically significant in case-control studies (OR 3.93, 95% CI 2.36-6.53) and cohort studies (OR 1.70, 95% CI 1.11-2.60). Besides, the borderline significant association between the duration of hyperglycemia and ROP was observed in case-control studies (MD = 1.96, 95% CI 0.90-3.03; adjusted OR = 1.08, 95% CI 1.01-1.15). Furthermore, we found that the mean blood glucose level is higher in the ROP group than the non-ROP group in case-control studies (MD = 14.86, 95% CI 5.06-24.66) and the mean blood glucose level is higher in the hyperglycemia group than in the non-hyperglycemia group (MD = 86.54, 95% CI 11.03-162.05). However, after adjusting other confounders, the association between the mean blood glucose level and ROP varied in cohort studies (OR 1.96, 95% CI 1.23-3.13) and case-control studies (OR 1.02, 95% CI 1.00-1.05).Conclusion: This meta-analysis demonstrates that preterm infants with hyperglycemia have a tendency to increase the risk of ROP. Further studies will be required to achieve a firm conclusion for hyperglycemia and ROP and promote a better understanding of the prevention of ROP.Trial registration: CRD42021228733 What is Known: • Hyperglycemia including the duration and daily mean blood glucose concentration has been associated with the risk of developing ROP in some clinical studies. Current evidence cannot reach a consensus on whether neonatal hyperglycemia is a risk factor for ROP. What is New: • This meta-analysis demonstrates that preterm infants with hyperglycemia have a tendency to increase the risk of ROP. • While the association between the mean blood glucose level and ROP remains inconclusive.
Keywords: Blood glucose; Hyperglycemia; Meta-analysis; Retinopathy of prematurity; Review.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Hyperglycemia as a risk factor for the development of retinopathy of prematurity.BMC Pediatr. 2013 May 16;13:78. doi: 10.1186/1471-2431-13-78. BMC Pediatr. 2013. PMID: 23679669 Free PMC article.
-
Thresholds of glycemia, insulin therapy, and risk for severe retinopathy in premature infants: A cohort study.PLoS Med. 2020 Dec 11;17(12):e1003477. doi: 10.1371/journal.pmed.1003477. eCollection 2020 Dec. PLoS Med. 2020. PMID: 33306685 Free PMC article.
-
Effects of Neonatal Hyperglycemia on Retinopathy of Prematurity and Visual Outcomes at 7 Years of Age: A Matched Cohort Study.J Pediatr. 2020 Aug;223:42-50.e2. doi: 10.1016/j.jpeds.2020.04.059. J Pediatr. 2020. PMID: 32711750 Clinical Trial.
-
Outcomes of very preterm infants with neonatal hyperglycaemia: a systematic review and meta-analysis.Arch Dis Child Fetal Neonatal Ed. 2022 May;107(3):269-280. doi: 10.1136/archdischild-2020-321449. Epub 2021 Jul 30. Arch Dis Child Fetal Neonatal Ed. 2022. PMID: 34330757
-
Pregnancy-induced hypertension and retinopathy of prematurity: a meta-analysis.Acta Ophthalmol. 2021 Dec;99(8):e1263-e1273. doi: 10.1111/aos.14827. Epub 2021 Feb 21. Acta Ophthalmol. 2021. PMID: 33611839 Review.
Cited by
-
ROP: 80 Years after Its Detection - Where Do We Stand and How Long Will We Continue to Laser?Neonatology. 2024;121(5):608-615. doi: 10.1159/000538907. Epub 2024 May 22. Neonatology. 2024. PMID: 38776885 Free PMC article. Review.
-
The role of hepatic and renal functions in the development of retinopathy of prematurity: Is proteinuria a new risk factor?Int Ophthalmol. 2023 Feb;43(2):483-490. doi: 10.1007/s10792-022-02445-9. Epub 2022 Aug 5. Int Ophthalmol. 2023. PMID: 35930082
-
Time-Restricted Eating Improves Glycemic Control in Patients with Type 2 Diabetes: A Meta-Analysis and Systematic Review.Int J Mol Sci. 2025 Jul 29;26(15):7310. doi: 10.3390/ijms26157310. Int J Mol Sci. 2025. PMID: 40806442 Free PMC article. Review.
-
Delayed Macronutrients' Target Achievement in Parenteral Nutrition Reduces the Risk of Hyperglycemia in Preterm Newborn: A Randomized Controlled Trial.Nutrients. 2023 Mar 4;15(5):1279. doi: 10.3390/nu15051279. Nutrients. 2023. PMID: 36904278 Free PMC article. Clinical Trial.
-
Progress in the study of association between hematological indicators and retinopathy of prematurity (Review).Biomed Rep. 2024 Jun 6;21(2):111. doi: 10.3892/br.2024.1799. eCollection 2024 Aug. Biomed Rep. 2024. PMID: 38912168 Free PMC article. Review.
References
-
- Hartnett ME, Penn JS (2012) Mechanisms and management of retinopathy of prematurity. N Engl J Med 367:2515–2526. https://doi.org/10.1056/NEJMra1208129 - DOI - PubMed - PMC
-
- Lad EM, Hernandez-Boussard T, Morton JM, Moshfeghi DM (2009) Incidence of retinopathy of prematurity in the United States: 1997 through 2005. Am J Ophthalmol 148:451–458. https://doi.org/10.1016/j.ajo.2009.04.018 - DOI - PubMed
-
- Sapieha P, Joyal JS, Rivera JC, Kermorvant-Duchemin E, Sennlaub F, Hardy P, Lachapelle P, Chemtob S (2010) Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life. J Clin Invest 120:3022–3032. https://doi.org/10.1172/JCI42142 - DOI - PubMed - PMC
-
- Hellstrom A, Smith LE, Dammann O (2013) Retinopathy of prematurity. Lancet 382:1445–1457. https://doi.org/10.1016/S0140-6736(13)60178-6 - DOI - PubMed - PMC
-
- Beardsall K, Vanhaesebrouck S, Ogilvy-Stuart AL, Vanhole C, Palmer CR, Van Weissenbruch M, Midgley P, Thompson M, Thio M, Cornette L, Ossuetta I, Iglesias I, Theyskens C, De Jong M, Ahluwalia JS, De Zegher F, Dunger DB (2008) Early insulin therapy in very-low-birth-weight infants. N Engl J Med 359:1873–1884. https://doi.org/10.1056/NEJMoa0803725 - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical